cDNA accession Links to the sequence |
Tissue most 5' clones in red |
Match mRNA |
From bp to bp in mRNA |
From bp to bp in accs. |
Clone encodes complete protein (with AA variation) |
Features | Anomalies detected by AceView |
Accession match over (% length) |
Base differences relative to genome (% identity) |
AW854721 | colon | .e | 668 to 1008 | 343 to 3 | 341/343 (99 %) | 0 diff (100 %id) | |||
AY374142 | .a | 315 to 1847 | 1 to 1533 | tiling clone, AAA | 1533/1533 (100 %) | 0 diff (100 %id) | |||
BC113644 | Brain, cerebellum, PCR rescued clones | .a | 370 to 1848 | 1 to 1479 | 1479/1479 (100 %) | 1 diff (100.0 %id) | |||
TI_1243020351 | .a | 370 to 1455 | 42 to 1115 | AAA | 1074/1235 (86 %) | 34 diff (97.3 %id) | |||
TI_1243022711 | .a | 859 to 1785 | 7 to 936 | 930/936 (99 %) | 14 diff (98.6 %id) | ||||
TI_1243022719 | .a | 1533 to 1858 | 1 to 323 | 323/724 (44 %) | 7 diff (99.1 %id) | ||||
TI_2194628966 | .a | 731 to 1848 | 1172 to 57 | Submitted on the opposite strand | 1116/1305 (85 %) | 9 diff (99.4 %id) | |||
TI_2194629345 | .c | 1 to 1095 | 62 to 1147 | Submitted on the opposite strand | 1089/1267 (85 %) | 21 diff (98.4 %id) | |||
TI_2194630979 | .c | 1 to 1124 | 64 to 1178 | A107L F109S S110L V111* | Submitted on the opposite strand | 1115/1229 (90 %) | 23 diff (98.2 %id) | ||
BQ310586 | breast | .a | 2375 to 2918 | 1 to 542 | 542/542 (100 %) | 10 diff (98.2 %id) | |||
BQ310588 | breast | .a | 1212 to 1631 | 425 to 8 | 418/431 (96 %) | 0 diff (100 %id) | |||
BQ310589 | breast | .a | 2351 to 2937 | 1 to 586 | tiling clone, | 586/587 (99 %) | 5 diff (99.2 %id) | ||
BQ310614 | breast | .a | 2375 to 2918 | 1 to 542 | 542/542 (100 %) | 10 diff (98.2 %id) | |||
BX106042 | heart | .a | 2650 to 3329 | 1 to 683 | 683/683 (100 %) | 3 diff (99.6 %id) | |||
CD237718 | Pituitary | .e | 484 to 1152 | 1 to 670 | tiling clone, AAA | 670/670 (100 %) | 9 diff (98.7 %id) | ||
CN296726 | embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells | .a | 436 to 1135 | 1 to 700 | 700/703 (99 %) | 2 diff (99.8 %id) | |||
CN296727 | embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells | .c | 9 to 451 | 2 to 444 | 443/444 (99 %) | 6 diff (98.7 %id) | |||
CR747040 | melanotic melanoma, skin | .a | 845 to 1346 | 9 to 510 | 502/510 (98 %) | 10 diff (98.1 %id) | |||
AV711374 | adrenal cortico adenoma for Cushing'ssyndrome | .e | 17 to 595 | 1 to 582 | A2G G14V | 582/748 (77 %) | 14 diff (98.2 %id) | ||
DQ005576 | .a | 1 to 1393 | 1 to 1393 | tiling clone, | 1393/1395 (99 %) | 2 diff (99.9 %id) | |||
DW425806 | Liver | .f | 1 to 267 | 18 to 284 | tiling clone, | 267/284 (94 %) | 6 diff (97.9 %id) | ||
DW464886 | Liver | .e | 1134 to 1478 | 17 to 361 | tiling clone, | 345/361 (95 %) | 6 diff (98.4 %id) | ||
DW467648 | Liver | .a | 366 to 698 | 13 to 345 | 333/345 (96 %) | 7 diff (98.0 %id) | |||
FN050124 | breast carcinoma | .a | 3316 to 3416 | 1 to 101 | 101/101 (100 %) | 0 diff (100 %id) | |||
FN060061 | breast carcinoma | .a | 3336 to 3416 | 81 to 1 | Submitted on the opposite strand | 81/81 (100 %) | 0 diff (100 %id) | ||
AV700213 | hepatocellular carcinoma | .a | 1231 to 1753 | 142 to 663 | AAA | Submitted on the opposite strand | 522/663 (78 %) | 13 diff (98.1 %id) | |
DB475464 | hippocampus | .a | 373 to 1044 | 1 to 671 | 671/671 (100 %) | 2 diff (99.8 %id) | |||
DB544288 | hippocampus | .a | 2929 to 3416 | 1 to 488 | Submitted on the opposite strand | 488/488 (100 %) | 0 diff (100 %id) | ||
DB481519 | hippocampus | .a | 373 to 1091 | 1 to 718 | 718/725 (99 %) | 8 diff (98.9 %id) | |||
DB550338 | hippocampus | .a | 2700 to 3416 | 1 to 718 | Submitted on the opposite strand | 718/718 (100 %) | 5 diff (99.4 %id) | ||
R88881 | brain | .a | 959 to 1315 | 11 to 371 | 361/371 (97 %) | 12 diff (96.8 %id) | |||
N51684 | multiple sclerosis lesions | .a | 2954 to 3416 | 463 to 1 | fully sequenced, | 463/463 (100 %) | 2 diff (99.6 %id) | ||
N51782 | multiple sclerosis lesions | .a | 2714 to 2984 | 1 to 275 | fully sequenced, | 275/275 (100 %) | 2 diff (99.3 %id) | ||
AA022633 | heart | .a | 3138 to 3419 | 281 to 1 | fully sequenced, | 281/281 (100 %) | 1 diff (99.7 %id) | ||
AA022781 | heart | .a | 2650 to 3141 | 1 to 493 | fully sequenced, | 493/493 (100 %) | 3 diff (99.4 %id) | ||
W84858 | liver and spleen | .a | 1804 to 2235 | 1 to 432 | 432/432 (100 %) | 2 diff (99.6 %id) | |||
W84859 | liver and spleen | .a | 3035 to 3416 | 384 to 1 | 384/384 (100 %) | 5 diff (98.7 %id) | |||
AA293149 | ovarian tumor, ovary | .a | 1545 to 1867 | 1 to 323 | 323/323 (100 %) | 1 diff (99.7 %id) | |||
AA476843 | ovarian tumor, ovary | .a | 1545 to 2013 | 1 to 466 | 466/466 (100 %) | 4 diff (99.2 %id) | |||
AA442226 | .a | 1944 to 2389 | 1 to 445 | 445/445 (100 %) | 11 diff (97.6 %id) | ||||
AA442892 | .a | 3030 to 3419 | 390 to 1 | 390/390 (100 %) | 0 diff (100 %id) | ||||
AA779679 | .a | 2899 to 3419 | 522 to 2 | 521/522 (99 %) | 0 diff (100 %id) | ||||
AA602310 | normal prostate, Prostate | .a | 2921 to 3416 | 508 to 12 | AAA | 497/497 (100 %) | 3 diff (99.4 %id) | ||
AA877928 | colon, colon tumor RER+ | .a | 2986 to 3416 | 445 to 15 | AAA | 431/431 (100 %) | 3 diff (99.4 %id) | ||
AA887324 | Kidney | .a | 1893 to 2005 | 113 to 1 | 113/113 (100 %) | 0 diff (100 %id) | |||
AA887326 | Kidney | .a | 1830 to 2006 | 177 to 1 | 177/177 (100 %) | 3 diff (98.4 %id) | |||
AI080410 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .a | 3041 to 3416 | 376 to 1 | 376/376 (100 %) | 2 diff (99.5 %id) | |||
AI049781 | .a | 3006 to 3418 | 413 to 1 | 413/413 (100 %) | 0 diff (100 %id) | ||||
AI129521 | uterus | .a | 1401 to 1855 | 456 to 2 | 455/456 (99 %) | 6 diff (98.7 %id) | |||
AI192607 | lung | .a | 2976 to 3419 | 447 to 3 | 445/447 (99 %) | 0 diff (100 %id) | |||
AI333643 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .a | 1374 to 1847 | 491 to 18 | AAA | 474/474 (100 %) | 10 diff (97.9 %id) | ||
AI362530 | poorly differentiated adenocarcinoma withsignet ring cell features, stomach | .e | 750 to 1139 | 390 to 1 | tiling clone, | 390/390 (100 %) | 0 diff (100 %id) | ||
AI370447 | .a | 3037 to 3419 | 382 to 1 | 382/382 (100 %) | 1 diff (99.8 %id) | ||||
AI688453 | colon | .a | 3120 to 3416 | 311 to 15 | AAA | 297/297 (100 %) | 3 diff (99.0 %id) | ||
AI936541 | pooled | .a | 550 to 706 | 157 to 1 | 157/157 (100 %) | 0 diff (100 %id) | |||
AI863797 | colon, colon tumor, RER+ | .a | 751 to 1032 | 282 to 1 | 282/282 (100 %) | 0 diff (100 %id) | |||
AW140009 | .a | 3029 to 3416 | 405 to 18 | AAA | 388/388 (100 %) | 4 diff (99.0 %id) | |||
AW271625 | Kidney | .a | 2959 to 3419 | 463 to 3 | 461/463 (99 %) | 0 diff (100 %id) | |||
AW304423 | lung, two pooled squamous cell carcinomas | .a | 2988 to 3419 | 432 to 1 | 432/432 (100 %) | 2 diff (99.6 %id) | |||
BE042868 | carcinoid, lung | .a | 2931 to 3419 | 490 to 2 | tiling clone, | 489/490 (99 %) | 0 diff (100 %id) | ||
BE349070 | malignant melanoma, metastatic to lymphnode, skin | .a | 3000 to 3419 | 422 to 3 | 420/422 (99 %) | 0 diff (100 %id) | |||
BF438491 | brain, glioblastoma (pooled) | .a | 3144 to 3416 | 273 to 1 | 273/273 (100 %) | 2 diff (99.3 %id) | |||
BF000150 | colon, colon tumor, RER+ | .a | 2969 to 3418 | 450 to 1 | 450/450 (100 %) | 5 diff (98.9 %id) | |||
BF038945 | adenocarcinoma, ovary | .a | 2538 to 3239 | 695 to 1 | Submitted on the opposite strand | 695/695 (100 %) | 33 diff (95.3 %id) | ||
BG258429 | embryonal carcinoma, cell line, testis | .e | 62 to 940 | 1 to 890 | tiling clone, | 890/894 (99 %) | 59 diff (93.5 %id) | ||
BC029123 | Colon, Kidney, Stomach, adult, whole pooled | .a | 381 to 2024 | 1 to 1642 | available from MGC, AAA | 1642/1642 (100 %) | 3 diff (99.9 %id) | ||
BI760809 | pooled colon, kidney, stomach | .a | 381 to 994 | 1 to 611 | available from MGC, | 611/611 (100 %) | 3 diff (99.6 %id) | ||
BI554129 | anaplastic oligodendroglioma with 1p/19qloss, brain | .a | 516 to 1145 | 146 to 778 | 633/778 (81 %) | 14 diff (98.3 %id) | |||
BQ002294 | Chondrosarcoma, Left Pelvis | .a | 2968 to 3416 | 467 to 19 | AAA | 449/449 (100 %) | 1 diff (99.8 %id) | ||
BQ213852 | melanotic melanoma, skin | .a | 849 to 1503 | 1 to 670 | 670/987 (67 %) | 32 diff (96.8 %id) | |||
BU169269 | epidermoid carcinoma, cell line, salivary gland | .a | 1695 to 2580 | 1 to 894 | tiling clone, | 894/910 (98 %) | 28 diff (97.0 %id) | ||
BQ898111 | dorsal root ganglia | .d | 1 to 923 | 1 to 928 | exact | tiling clone, | 928/929 (99 %) | 9 diff (99.1 %id) | |
BQ718186 | sympathetic trunk | .f | 145 to 1094 | 1 to 963 | E127G D128R W129L S130V D131R ... | tiling clone, | 963/990 (97 %) | 26 diff (97.4 %id) | |
BQ955379 | epidermoid carcinoma, cell line, lung | .a | 2659 to 3416 | 1 to 758 | AAA | 758/758 (100 %) | 4 diff (99.5 %id) | ||
BU930097 | Prostate | .e | 1 to 704 | 1 to 712 | exact | tiling clone, | 712/823 (86 %) | 19 diff (97.7 %id) | |
BC143913 | Brain, cerebellum, PCR rescued clones | .c | 1 to 1565 | 1 to 1565 | exact | tiling clone, | 1565/1565 (100 %) | 1 diff (100.0 %id) | |
TI_57147012 | .a | 381 to 994 | 30 to 640 | 611/640 (95 %) | 9 diff (98.6 %id) | ||||
TI_44385137 | .a | 516 to 1145 | 201 to 833 | 633/778 (81 %) | 14 diff (98.3 %id) | ||||
CB164698 | Liver | .a | 2614 to 3153 | 1 to 540 | 540/540 (100 %) | 1 diff (99.9 %id) | |||
NM_199227.1 | .a | 315 to 1847 | 1 to 1533 | RefSeq, AAA | 1533/1533 (100 %) | 0 diff (100 %id) | |||
DB010991 | colon, tumor tissue | .b | 1 to 454 | 2 to 455 | tiling clone, capped | 454/454 (100 %) | 0 diff (100 %id) | ||
DB335328 | colon, tumor tissue | .b | 1040 to 1594 | 555 to 1 | tiling clone, | 555/565 (98 %) | 0 diff (100 %id) | ||
TI_149296966 | .a | 2725 to 3416 | 776 to 90 | AAA | 687/890 (77 %) | 5 diff (99.5 %id) | |||
BM982111 | lung, Primary Lung Cystic Fibrosis EpithelialCells | .a | 2811 to 3416 | 624 to 19 | AAA | 606/606 (100 %) | 0 diff (100 %id) | ||
CA427844 | Bone, Subchondral Bone | .a | 1025 to 1847 | 836 to 19 | AAA | 818/818 (100 %) | 5 diff (99.4 %id) | ||
BQ445926 | Knee, Osteoarthritic Cartilage | .a | 2698 to 3416 | 737 to 19 | tiling clone, AAA | 719/719 (100 %) | 0 diff (100 %id) | ||
BU632792 | cell lines, Chondrosarcoma | .a | 2784 to 3416 | 649 to 19 | AAA | 631/631 (100 %) | 2 diff (99.7 %id) | ||
BU623229 | cell lines, Chondrosarcoma | .a | 2732 to 3416 | 699 to 19 | AAA | 681/681 (100 %) | 5 diff (99.3 %id) | ||
TI_2194630976 | .a | 849 to 1503 | 1 to 670 | Submitted on the opposite strand, submitted on the opposite strand | 670/987 (67 %) | 32 diff (96.8 %id) | |||
BQ310587 | breast | .a | 1695 to 2580 | 1 to 894 | tiling clone, | Suspected internal deletion, this clone was ignored | 894/910 (98 %) | 28 diff (97.0 %id) | |
BQ310615 | breast | .a | 1695 to 2580 | 1 to 894 | tiling clone, | Suspected internal deletion, this clone was ignored | 894/910 (98 %) | 28 diff (97.0 %id) | |
FN145460 | breast carcinoma | .d | 1 to 923 | 1 to 928 | tiling clone, | 928/929 (99 %) | 9 diff (99.1 %id) | ||
AV681871 | hepatocellular carcinoma | .f | 145 to 1094 | 1 to 963 | tiling clone, | This clone was ignored | 963/990 (97 %) | 26 diff (97.4 %id) | |
DA571261 | whole embryo, mainly head | .a | 2659 to 3416 | 1 to 758 | capped | 758/758 (100 %) | 4 diff (99.5 %id) | ||
DB358101 | whole embryo, mainly head | .a | 2659 to 3416 | 1 to 758 | 758/758 (100 %) | 4 diff (99.5 %id) | |||
DA666398 | .e | 1 to 704 | 1 to 712 | tiling clone, capped | This clone was ignored | 712/823 (86 %) | 19 diff (97.7 %id) | ||
DB322128 | .c | 1 to 1565 | 1 to 1565 | tiling clone, | This clone was ignored | 1565/1565 (100 %) | 1 diff (100.0 %id) | ||
TI_57147012 | .a | 381 to 994 | 30 to 640 | 611/640 (95 %) | 9 diff (98.6 %id) | ||||
TI_44385137 | .a | 516 to 1145 | 201 to 833 | 633/778 (81 %) | 14 diff (98.3 %id) | ||||
CB164698 | Liver | .a | 2614 to 3153 | 1 to 540 | 540/540 (100 %) | 1 diff (99.9 %id) | |||
NM_199227.1 | .a | 315 to 1847 | 1 to 1533 | RefSeq, AAA | 1533/1533 (100 %) | 0 diff (100 %id) | |||
DB010991 | colon, tumor tissue | .b | 1 to 454 | 2 to 455 | tiling clone, capped | 454/454 (100 %) | 0 diff (100 %id) | ||
DB335328 | colon, tumor tissue | .b | 1040 to 1594 | 555 to 1 | tiling clone, | 555/565 (98 %) | 0 diff (100 %id) | ||
TI_149296966 | .a | 2725 to 3416 | 776 to 90 | AAA | 687/890 (77 %) | 5 diff (99.5 %id) | |||
BM982111 | lung, Primary Lung Cystic Fibrosis EpithelialCells | .a | 2811 to 3416 | 624 to 19 | AAA | 606/606 (100 %) | 0 diff (100 %id) | ||
BM982111 | lung, Primary Lung Cystic Fibrosis EpithelialCells | .a | 2811 to 3416 | 624 to 19 | AAA | 606/606 (100 %) | 0 diff (100 %id) | ||
CA427844 | Bone, Subchondral Bone | .a | 1025 to 1847 | 836 to 19 | AAA | 818/818 (100 %) | 5 diff (99.4 %id) | ||
CA427844 | Bone, Subchondral Bone | .a | 1025 to 1847 | 836 to 19 | AAA | 818/818 (100 %) | 5 diff (99.4 %id) | ||
BQ445926 | Knee, Osteoarthritic Cartilage | .a | 2698 to 3416 | 737 to 19 | tiling clone, AAA | 719/719 (100 %) | 0 diff (100 %id) | ||
BQ445926 | Knee, Osteoarthritic Cartilage | .a | 2698 to 3416 | 737 to 19 | tiling clone, AAA | 719/719 (100 %) | 0 diff (100 %id) | ||
BU632792 | cell lines, Chondrosarcoma | .a | 2784 to 3416 | 649 to 19 | AAA | 631/631 (100 %) | 2 diff (99.7 %id) | ||
BU632792 | cell lines, Chondrosarcoma | .a | 2784 to 3416 | 649 to 19 | AAA | 631/631 (100 %) | 2 diff (99.7 %id) | ||
BU623229 | cell lines, Chondrosarcoma | .a | 2732 to 3416 | 699 to 19 | AAA | 681/681 (100 %) | 5 diff (99.3 %id) | ||
BU623229 | cell lines, Chondrosarcoma | .a | 2732 to 3416 | 699 to 19 | AAA | 681/681 (100 %) | 5 diff (99.3 %id) |
? | Gene Summary | Gene on genome | mRNA:.a, .b, .c, .d, .e, .f | Alternative mRNAs features, proteins, introns, exons, sequences | Expression Tissue | Function, regulation, related genes DC |